Skip to content

The neuroprotective efficacy of cholecalciferol: Targeting oxidative stress and NF-κB-mediated neuroinflammation in a valproic acid-induced autism model.

Nov 2026 · Tissue & Cell · Vol 105, pp. 104135 · 0 citations · 94 references
Medicine

Abstract

Background

Autism spectrum disorder (ASD) is a multifactorial neurodevelopmental condition characterized by repetitive behaviors, heightened anxiety and altered exploratory motivation, which are closely linked to oxidative stress, neuroinflammation, and glial dysfunction. Although vitamin D₃ (cholecalciferol) exhibits promising neuroprotective and anti-inflammatory properties that may counteract these effects, comparative evidence evaluating whether early prophylactic supplementation provides superior neuroprotection compared to late therapeutic administration, as well as its precise modulation of the cerebral NF-κB/glial axis, remains lacking.

Aim

This study aimed to evaluate and compare the prophylactic versus therapeutic effects of vitamin D₃ against valproic acid (VPA)-induced oxidative, neuroinflammatory, and apoptotic alterations in the frontal cortex of rat pups, correlating these neuromolecular changes with behavioral performance.

Methods

Forty male albino rat pups were randomly divided into five groups (n = 8/group): Control, Vit. D, Val. A., Vit. D + Val. A, and Val. A. + Vit. D. Vitamin D₃ (80,000 IU/kg, i.m.) was administered on postnatal days (PND) 7 and 14 in the protective group, and on PND 21 and 28 in the therapeutic group, while VPA (400 mg/kg, s.c.) was given as a single dose on PND 14. Behavioral, biochemical, molecular (qPCR), histopathological, and immunohistochemical studies were done to assess cortical oxidative stress, NF-κB-mediated neuroinflammation, glial activation, and neuronal integrity.

Results

VPA-exposed rats exhibited increased repetitive behavior, heightened anxiety-like responses, and reduced central exploration in the open field test, along with elevated MDA levels, and reduced SOD activity, along with upregulation of pro-inflammatory and pro-apoptotic genes (TNF-α, IL-1β, IL-6, BAX, and Caspase-3). Histological examination revealed neuronal degeneration, glial activation, and NF-κB immunoreactivity in the frontal cortex. Vitamin D₃ administration, both preventively and therapeutically, significantly mitigated these behavioral, biochemical, molecular, and histological alterations with significantly more pronounced neuroprotection observed in the early prophylactic group (Vit. D + Val. A.).

Conclusion

Vitamin D₃ exerts protective and restorative effects against VPA-induced autistic-like alterations in the developing rat frontal cortex through attenuation of oxidative stress, suppression of the NF-κB inflammatory cascade, inhibition of glial activation, and promotion of neuronal survival and neurogenesis. Importantly, the extent of neuroprotection is highly timing-dependent, emphasizing the critical value of early prophylactic supplementation during key postnatal neurodevelopmental windows.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.